Rimota-Gd: Paramagnetic Probe for In Vivo MRI Studies of the Cannabinoid 1 Receptor Distribution in the Mouse Brain

Area of Science:

• Neuroscience
• Radiology
• Pharmacology

Background:

• Cannabinoid 1 receptor (CB1) plays a crucial role in the central nervous system, regulating energy balance, pain, and addiction.
• Previous studies on CB1 distribution relied on in vitro methods or lower-resolution in vivo techniques like positron emission tomography (PET).

Purpose of the Study:

• To develop and validate a high-resolution magnetic resonance imaging (MRI) technique for investigating CB1 distribution in mouse brains.
• To create a specific ligand for in vivo neuroimaging of CB1.

Main Methods:

• Development of a paramagnetic probe, Rimota-Gd, by conjugating the CB1 antagonist rimonabant acid to a gadolinium chelator.
• Utilizing MRI with Rimota-Gd to map CB1 spatial distribution in mouse brains.
• Comparison of MRI results with those obtained using the PET radioligand [18F]MK-9470.

Main Results:

• Successful development and validation of the Rimota-Gd probe for MRI.
• High spatial resolution mapping of CB1 distribution across the mouse brain using MRI.
• Demonstration of MRI's capability for in vivo neuroimaging of CB1.

Conclusions:

• Rimota-Gd enables in vivo MRI imaging of CB1 distribution with high spatial resolution.
• This technique provides a new roadmap for studying other receptors using whole-brain imaging.
• The developed MRI method expands upon previous in vitro and PET imaging capabilities for CB1.